Xynomic Pharmaceuticals, Inc. is a US incorporated biopharmaceutical company founded by US-China industry veterans and successful entrepreneurs. Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies. Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner. Xynomic Pharma is headquartered in the Shanghai with major operations in US and Shanghai, China.
View Top Employees from Xynomic PharmaWebsite | http://www.xynomicpharma.com/ |
Revenue | $5 million |
Employees | 12 (12 on RocketReach) |
Founded | 2016 |
Address | 3500 South DuPont Highway Suite SS101, Dover, Delaware 19901, US |
Phone | +86 21 5418 0212 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Medical, Pharmaceutical |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Xynomic Pharma employee's phone or email?
The Xynomic Pharma annual revenue was $5 million in 2024.
12 people are employed at Xynomic Pharma.
Xynomic Pharma is based in Dover, Delaware.
The NAICS codes for Xynomic Pharma are [325, 3254, 32541, 32].
The SIC codes for Xynomic Pharma are [283, 28].